NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 213 filers reported holding NEOGENOMICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $177,203 | +31.5% | 10,952 | 0.0% | 0.01% | +14.3% |
| Q3 2023 | $134,709 | -23.5% | 10,952 | 0.0% | 0.01% | -22.2% |
| Q2 2023 | $175,998 | -7.7% | 10,952 | 0.0% | 0.01% | -10.0% |
| Q1 2023 | $190,674 | +190574.0% | 10,952 | +1.6% | 0.01% | +66.7% |
| Q4 2022 | $100 | -99.9% | 10,779 | -1.4% | 0.01% | 0.0% |
| Q3 2022 | $94,000 | +6.8% | 10,933 | +1.4% | 0.01% | +20.0% |
| Q2 2022 | $88,000 | -32.8% | 10,779 | 0.0% | 0.01% | -16.7% |
| Q1 2022 | $131,000 | -64.4% | 10,779 | 0.0% | 0.01% | -62.5% |
| Q4 2021 | $368,000 | -29.2% | 10,779 | 0.0% | 0.02% | -33.3% |
| Q3 2021 | $520,000 | +6.8% | 10,779 | 0.0% | 0.02% | +4.3% |
| Q2 2021 | $487,000 | -6.3% | 10,779 | 0.0% | 0.02% | -11.5% |
| Q1 2021 | $520,000 | -10.3% | 10,779 | 0.0% | 0.03% | -16.1% |
| Q4 2020 | $580,000 | +45.7% | 10,779 | 0.0% | 0.03% | +29.2% |
| Q3 2020 | $398,000 | +19.2% | 10,779 | 0.0% | 0.02% | +9.1% |
| Q2 2020 | $334,000 | +12.1% | 10,779 | 0.0% | 0.02% | -8.3% |
| Q1 2020 | $298,000 | -48.9% | 10,779 | -46.0% | 0.02% | -33.3% |
| Q4 2019 | $583,000 | +53.0% | 19,947 | 0.0% | 0.04% | +38.5% |
| Q3 2019 | $381,000 | -13.0% | 19,947 | 0.0% | 0.03% | -13.3% |
| Q2 2019 | $438,000 | +7.4% | 19,947 | 0.0% | 0.03% | +3.4% |
| Q1 2019 | $408,000 | -28.8% | 19,947 | -56.1% | 0.03% | -37.0% |
| Q4 2018 | $573,000 | -46.7% | 45,472 | -35.1% | 0.05% | -35.2% |
| Q3 2018 | $1,075,000 | +17.1% | 70,042 | 0.0% | 0.07% | +10.9% |
| Q2 2018 | $918,000 | +60.5% | 70,042 | 0.0% | 0.06% | +60.0% |
| Q1 2018 | $572,000 | -7.9% | 70,042 | 0.0% | 0.04% | -9.1% |
| Q4 2017 | $621,000 | -20.4% | 70,042 | 0.0% | 0.04% | -24.1% |
| Q3 2017 | $780,000 | +24.2% | 70,042 | 0.0% | 0.06% | +18.4% |
| Q2 2017 | $628,000 | +13.6% | 70,042 | 0.0% | 0.05% | +8.9% |
| Q1 2017 | $553,000 | -7.8% | 70,042 | 0.0% | 0.04% | -15.1% |
| Q4 2016 | $600,000 | – | 70,042 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |